Conclusion
In conclusion, the application and development of network pharmacology have excavated new insights into the treatment of sepsis, including the treatment mechanism of the disease: the complex network relationship of multi-target, multi-channel, and multi-component, which also makes us a new way of thinking for the drug development and selection of this refractory disease. In addition, it also shows attractive charm in the treatment of complex diseases such as cancer, cardiovascular disease, mental disease, and new coronavirus pneumonia. However, network pharmacology still faces many problems and challenges, such as the lack of uniformity in the diversity of databases, the lack of standardization in data screening, and the poor repeatability and convertibility of data results. Although the development of computer science, genomics, and systems biology may promote the development of network pharmacology in more disease fields, it is still necessary to explore new methods for the treatment of complex diseases such as sepsis.